Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.390
+0.020 (1.46%)
At close: Mar 25, 2026, 4:00 PM EDT
1.400
+0.010 (0.72%)
After-hours: Mar 25, 2026, 5:26 PM EDT
Metagenomi Therapeutics Market Cap
Metagenomi Therapeutics has a market cap or net worth of $52.29 million as of March 25, 2026. Its market cap has decreased by -31.84% in one year.
Market Cap
52.29M
Enterprise Value
-68.23M
1-Year Change
-31.84%
Ranking
Category
Stock Price
$1.39
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi Therapeutics's market cap has decreased from $562.92M to $52.29M, a decrease of -90.71%. That is a compound annual growth rate of -67.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 51.54M | -15.27% |
| Dec 31, 2025 | 60.83M | -54.98% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OnKure Therapeutics | 54.42M |
| Lipocine | 53.73M |
| Mereo BioPharma Group | 53.63M |
| Immutep | 52.99M |
| Actuate Therapeutics | 51.37M |
| Radiopharm Theranostics | 48.91M |
| OS Therapies | 48.60M |
| Xilio Therapeutics | 48.40M |